Nuvation Bio Statistics

Total Valuation

Nuvation Bio has a market cap or net worth of $580.00 million. The enterprise value is -$27.20 million.

Market Cap	580.00M
Enterprise Value	-27.20M

Important Dates

The next estimated earnings date is Thursday, May 2, 2024, after market close.

Earnings Date	May 2, 2024
Ex-Dividend Date	n/a

Share Statistics

Nuvation Bio has 218.05 million shares outstanding. The number of shares has increased by 1.00% in one year.

Shares Outstanding	218.05M
Shares Change (YoY)	+1.00%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	24.53%
Owned by Institutions (%)	55.07%
Float	135.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.96
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 44.11, with a Debt / Equity ratio of 0.01.

Current Ratio	44.11
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -12.20% and return on invested capital (ROIC) is -16.39%.

Return on Equity (ROE)	-12.20%
Return on Assets (ROA)	-11.90%
Return on Capital (ROIC)	-16.39%
Revenue Per Employee	n/a
Profits Per Employee	-$1.49M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.00% in the last 52 weeks. The beta is 1.37, so Nuvation Bio's price volatility has been higher than the market average.

Beta (1Y)	1.37
52-Week Price Change	+52.00%
50-Day Moving Average	2.51
200-Day Moving Average	1.75
Relative Strength Index (RSI)	46.31
Average Volume (30 Days)	1,325,356

Short Selling Information

The latest short interest is 3.01 million, so 1.38% of the outstanding shares have been sold short.

Short Interest	3.01M
Short Previous Month	2.65M
Short % of Shares Out	1.38%
Short % of Float	2.21%
Short Ratio (days to cover)	1.44

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-99.82M
Pretax Income	-75.80M
Net Income	-75.80M
EBITDA	-75.65M
EBIT	-75.80M
Earnings Per Share (EPS)	-$0.35

Full Income Statement

Balance Sheet

The company has $611.21 million in cash and $4.01 million in debt, giving a net cash position of $607.21 million or $2.78 per share.

Cash & Cash Equivalents	611.21M
Total Debt	4.01M
Net Cash	607.21M
Net Cash Per Share	$2.78
Equity / Book Value	605.12M
Book Value Per Share	2.78
Working Capital	602.46M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$68.00 million and capital expenditures -$55,000, giving a free cash flow of -$68.05 million.

Operating Cash Flow	-68.00M
Capital Expenditures	-55,000
Free Cash Flow	-68.05M
FCF Per Share	-$0.31

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Nuvation Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.00%
Shareholder Yield	-1.00%
Earnings Yield	-13.07%
FCF Yield	-11.73%

Analyst Forecast

The average price target for Nuvation Bio is $6.33, which is 137.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.33
Price Target Difference	137.97%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	5.10%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2